1.Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review

作　　者：Turki A. Althunian ;Anthonius de Boer ;Olaf H. Klungel 等

出　　处：Trials. 2017 ;18(1):107.doi:10.1186/s13063-017-1859-x

出版社：BioMed Central

文章 ID：192526653

文章详细全文下载
2.Increasing the information provided by probabilistic sensitivity analysis: The relative density plot

作　　者：Joost W. Geenen ;Rick A. Vreman ;Cornelis Boersma 等

出　　处：Cost Effectiveness and Resource Allocation. 2020 ;18(1):1-10.doi:10.1186/s12962-020-00251-7

出版社：BioMed Central

文章 ID：257602348

文章详细全文下载
3.Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery

作　　者：Grace Wangge ;Olaf H Klungel ;Kit CB Roes 等

出　　处：Trials. 2011 ;12(1):A32.doi:10.1186/1745-6215-12-S1-A32

出版社：BioMed Central

文章 ID：215803052

文章详细
4.Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study

作　　者：Amr Makady ;Rachel R. J. Kalf ;Bettina Ryll 等

出　　处：Health and Quality of Life Outcomes. 2018 ;16(1):222.doi:10.1186/s12955-018-1047-z

出版社：BioMed Central

文章 ID：222396575

文章详细
5.Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes

作　　者：Shifteh Abedian ;Ali Abbasi ;Anthonius de Boer 等

出　　处：Scientific Reports. 2021 ;11(1):2794.doi:10.1038/s41598-021-82276-3

出版社：Springer Nature

文章 ID：259938949

文章详细全文下载
6.Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands

作　　者：Christine M. Cramer-van der Welle ;Marjon V. Verschueren ;Merel Tonn 等

出　　处：Scientific Reports. 2021 ;11(1):6306.doi:10.1038/s41598-021-85696-3

出版社：Springer Nature

文章 ID：259942379

文章详细全文下载
7.The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

作　　者：Rick A. Vreman ;Lourens T. Bloem ;Stijn van Oirschot 等

出　　处：International Journal of Health Policy and Management. 2022 ;11(5):642-650.doi:10.34172/ijhpm.2020.198

出版社：Kerman University of Medical Sciences

文章 ID：1038843431

文章详细

	有本地全文	4篇
	有全文链接	3篇

	Olaf H. Klungel	6篇
	Anthonius de Boer	3篇
	Rick A. Vreman	2篇
	Abbas Dehghan	1篇
	Ali Abbasi	1篇

	Amr Makady	1篇
	Anke M. Hövels	1篇
	Antonius de Boer	1篇
	Arno W Hoes	1篇
	Aukje K. Mantel-Teeuwisse	1篇
	Bas J. M. Peters	1篇
	Behrooz Z. Alizadeh	1篇
	Bettina Ryll	1篇
	Bruno H. Stricker	1篇
	Christine M. Cramer-van der Welle	1篇
	Cornelis Boersma	1篇
	Ewoudt M. W. van de Garde	1篇
	Franz M. N. H. Schramel	1篇
	Gerjan Navis	1篇
	Gilliosa Spurrier	1篇
	Grace Wangge	1篇
	Hans Hillege	1篇
	Harold Snieder	1篇
	Harry J. M. Groen	1篇
	Hubert GM Leufkens	1篇
	Ido Pen	1篇
	Jarno Hoekman	1篇
	Joost W. Geenen	1篇
	Kit CB Roes	1篇
	Lourens T. Bloem	1篇
	M. Arfan Ikram	1篇
	Marjon V. Verschueren	1篇
	Maryam Darvishian	1篇
	Menno E. van der Elst	1篇
	Merel Tonn	1篇
	Mirjam J Knol	1篇
	Olaf H Klungel	1篇
	Patrick Souverein	1篇
	Pim van der Harst	1篇
	Rachel R. J. Kalf	1篇

	自然科学总论	2篇
	自然科学研究方法	2篇
	社会学	1篇
	管理学	1篇
	预防医学、卫生学	1篇

	英国	6篇
	伊朗	1篇

全文

出版年度

作者

文章类型

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Olaf H Klungel")))) )) ) )"

	Scientific Reports	2篇
	Trials	2篇
	Cost Effectiveness and Resource Allocation	1篇
	Health and Quality of Life Outcomes	1篇
	International Journal of Health Policy and Management	1篇

	2022	1篇
	2021	2篇
	2020	1篇
	2018	1篇
	2017	1篇